Identification of TRAIL-inducing compounds highlights small molecule ONC201/TIC10 as a unique anti-cancer agent that activates the TRAIL pathway

BACKGROUND: We previously reported the identification of ONC201/TIC10, a novel small molecule inducer of the human TRAIL gene that improves efficacy-limiting properties of recombinant TRAIL and is in clinical trials in advanced cancers based on its promising safety and antitumor efficacy in several...

Descripción completa

Detalles Bibliográficos
Autores principales: Allen, Joshua E, Krigsfeld, Gabriel, Patel, Luv, Mayes, Patrick A, Dicker, David T, Wu, Gen Sheng, El-Deiry, Wafik S
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428111/
https://www.ncbi.nlm.nih.gov/pubmed/25927855
http://dx.doi.org/10.1186/s12943-015-0346-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4428111/
https://www.ncbi.nlm.nih.gov/pubmed/25927855
http://dx.doi.org/10.1186/s12943-015-0346-9

Ejemplares similares